middle.news
How Bio-Gene’s $2.45M Raise Accelerates Novel Insecticides to Market
8:22am on Thursday 31st of July, 2025 AEST
•
Agriculture
Read Story
How Bio-Gene’s $2.45M Raise Accelerates Novel Insecticides to Market
8:22am on Thursday 31st of July, 2025 AEST
Key Points
Completed $2.45 million capital raise via placement and Share Purchase Plan
Preparing to commence key regulatory safety studies for Flavocide
Ongoing scale-up and yield improvements in Qcide production
Leveraging US Department of Defense grants for product validation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE